Diagnostic Accuracy of DIAGNOdent Compared to ICDAS II

NCT05127356 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2022-05-31

No results posted yet for this study

Summary

There is a paradigm shift in conservative dentistry by substituting the surgical model with the medical model of treatment. Early detection of initial carious lesions will aid in clinical decision making during management ; either no care advised, preventive care advised or operative care advised. According to recent systematic reviews meticulous visual examination using ICDAS II presented a substantial level of reproducibility and accuracy for assessment of carious lesions and was considered the reference for clinical visual assessment . However, visual examination is subjective and is highly dependent on the dentist's skills and experience, with high specificity and low sensitivity. New devices have been developed to detect and quantify incipient demineralization. Besides visual detection systems, laser fluorescence assessment can be considered a suitable method. In vitro data suggested that the visual examination and fluorescence method have similar accuracy to detect initial carious lesions.

Conditions

  • Caries; Initial

Interventions

DEVICE

DIAGNOdent

Laser fluorescence device

DIAGNOSTIC_TEST

ICDAS II

International Caries Detection and Assessment System (ICDAS II)

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Omar O Shaalan, PhD · Lecturer, Conservative Dentistry Department, Faculty of Dentistry, Cairo University

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-04-30
Completion
2022-05-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05127356 on ClinicalTrials.gov